XML 50 R22.htm IDEA: XBRL DOCUMENT v3.6.0.2
Selected Quarterly Financial Information (Unaudited)
12 Months Ended
Dec. 31, 2016
Selected Quarterly Financial Information (Unaudited)  
Selected Quarterly Financial Information (Unaudited)

13.Selected Quarterly Financial Information (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

March 31, 

 

June 30, 

 

September 30, 

 

December 31,

 

(in thousands, except per share amounts)

 

2016

 

2016

 

2016

 

2016

 

Net sales

    

$

23,092

    

$

28,556

    

$

29,577

    

$

33,172

 

Cost of sales

 

 

3,121

 

 

4,359

 

 

3,886

 

 

4,811

 

Gross profit

 

 

19,971

 

 

24,197

 

 

25,691

 

 

28,361

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

12,288

 

 

15,120

 

 

16,854

 

 

20,494

 

Research and development

 

 

7,062

 

 

6,955

 

 

7,807

 

 

7,399

 

Total operating expenses

 

 

19,350

 

 

22,075

 

 

24,661

 

 

27,893

 

Income from operations

 

 

621

 

 

2,122

 

 

1,030

 

 

468

 

Total other income (expense), net

 

 

276

 

 

210

 

 

269

 

 

(431)

 

Provision for income taxes

 

 

 —

 

 

 —

 

 

140

 

 

(97)

 

Net income

 

$

897

 

$

2,332

 

$

1,159

 

$

134

 

Net income per share (1):

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.03

 

$

0.07

 

$

0.03

 

$

0.00

 

Diluted

 

$

0.03

 

$

0.06

 

$

0.03

 

$

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

March 31, 

 

June 30, 

 

September 30, 

 

December 31,

 

(in thousands, except per share amounts)

 

2015

 

2015

 

2015

 

2015

 

Net sales

    

$

14,666

    

$

17,754

    

$

19,004

    

$

20,276

 

Cost of sales

 

 

2,794

 

 

3,281

 

 

3,319

 

 

3,594

 

Gross profit

 

 

11,872

 

 

14,473

 

 

15,685

 

 

16,682

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

7,816

 

 

12,516

 

 

11,237

 

 

12,392

 

Research and development

 

 

5,240

 

 

7,339

 

 

6,173

 

 

6,295

 

Total operating expenses

 

 

13,056

 

 

19,855

 

 

17,410

 

 

18,687

 

Loss from operations

 

 

(1,184)

 

 

(5,382)

 

 

(1,725)

 

 

(2,005)

 

Loss on deconsolidation of DOSE

 

 

 —

 

 

(25,685)

 

 

 —

 

 

 —

 

Total other expense, net

 

 

(278)

 

 

(1,445)

 

 

(332)

 

 

(252)

 

Provision for income taxes

 

 

 —

 

 

 —

 

 

 —

 

 

33

 

Net loss

 

$

(1,462)

 

$

(32,512)

 

$

(2,057)

 

$

(2,290)

 

Net loss attributable to Glaukos Corporation

 

$

(966)

 

$

(31,928)

 

$

(2,057)

 

$

(2,290)

 

Net loss per share, basic and diluted, attributable to Glaukos Corporation stockholders(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.40)

 

$

(10.96)

 

$

(0.06)

 

$

(0.07)

 

Diluted

 

$

(0.40)

 

$

(10.96)

 

$

(0.07)

 

$

(0.07)

 

 

(1)

Net income or loss per share is computed independently for each of the quarters presented. Therefore, the sum of the quarterly per-share amounts will not necessarily equal the annual per share amount.